DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Escitalopram

Escitalopram

  • Efficacy of Treatments for Patients with Obsessive-Compulsive Disorder: a Systematic Review

    Efficacy of Treatments for Patients with Obsessive-Compulsive Disorder: a Systematic Review

  • Antinociceptive Effects of Monoamine Reuptake Inhibitors in Assays of Pain-Stimulated and Pain-Depressed Behaviors

    Antinociceptive Effects of Monoamine Reuptake Inhibitors in Assays of Pain-Stimulated and Pain-Depressed Behaviors

  • TAYSIDE PRESCRIBER Issue No

    TAYSIDE PRESCRIBER Issue No

  • Antidepressants for Functional Gastrointestinal Disorders

    Antidepressants for Functional Gastrointestinal Disorders

  • Adverse Effects of First-Line Pharmacologic Treatments of Major Depression in Older Adults

    Adverse Effects of First-Line Pharmacologic Treatments of Major Depression in Older Adults

  • Acute Inhibitory Effects of Antidepressants on Lacrimal Gland Secretion in the Anesthetized Rat

    Acute Inhibitory Effects of Antidepressants on Lacrimal Gland Secretion in the Anesthetized Rat

  • Prescribing Guidance for Citalopram and Escitalopram Hull and East Riding Prescribing Committee

    Prescribing Guidance for Citalopram and Escitalopram Hull and East Riding Prescribing Committee

  • Medication Guide Escitalopram Tablets (ES-Sye-TAL-Oh-Pram)

    Medication Guide Escitalopram Tablets (ES-Sye-TAL-Oh-Pram)

  • Review Article Monoamine Reuptake Inhibitors in Parkinson's Disease

    Review Article Monoamine Reuptake Inhibitors in Parkinson's Disease

  • Citalopram/Escitalopram (Celexa/Lexapro

    Citalopram/Escitalopram (Celexa/Lexapro

  • Lexapro (Escitalopram Oxalate) Tablets/Oral Solution NDA 21-323/NDA 21-365 Proposed Labeling Text

    Lexapro (Escitalopram Oxalate) Tablets/Oral Solution NDA 21-323/NDA 21-365 Proposed Labeling Text

  • Providers | Medications for Depression

    Providers | Medications for Depression

  • Selective Serotonin Reuptake Inhibitors Versus Placebo in Patients with Major Depressive Disorder

    Selective Serotonin Reuptake Inhibitors Versus Placebo in Patients with Major Depressive Disorder

  • Escitalopram Oxalate

    Escitalopram Oxalate

  • Lexapro® (LEX-A-Pro) Escitalopram Oxalate (ES-Sigh-Talo-Pram OX-A-Late) Consumer Medicine Information (CMI)

    Lexapro® (LEX-A-Pro) Escitalopram Oxalate (ES-Sigh-Talo-Pram OX-A-Late) Consumer Medicine Information (CMI)

  • Escitalopram

    Escitalopram

  • Antidepressant Medication

    Antidepressant Medication

  • Celexa® (Citalopram) Tablets Rx Only Suicidality and Antidepressant

    Celexa® (Citalopram) Tablets Rx Only Suicidality and Antidepressant

Top View
  • Formulary Brief: Selective Serotonin Reuptake Inhibitors (Ssris) -July 2019
  • Comparison of the Effects of Citalopram and Escitalopram on 5-Ht-Mediated Neuroendocrine Responses
  • View Board (#17–0011)
  • Drug Class Review Selective Serotonin Reuptake Inhibitors
  • Prescription Pattern of Antidepressants and the Potential for Personalized Medicine in the Qatari Population
  • Commonly Prescribed Psychotropic Medications
  • Antidepressants and Risk of Sudden Cardiac Death: a Network Meta-Analysis and Systematic Review
  • Pharmacy Pearls Antidepressant Management Algorithm for Pcps for Adults
  • Potential Therapeutic Utility of Triple Reuptake Inhibitors (Tris)
  • Protocol for Switching Patients from Escitalopram to Citalopram
  • Escitalopram (Lexapro)
  • PHG0702REV Lexa 11 19Hcsc 2/12/08 1:56 PM Page 1
  • Wo 2007/147134 A2
  • 9 Escitalopram for the Treatment of Depression in Adolescents
  • Medication Management of Anxiety & Depression
  • Atypical Antipsychotics
  • Guidelines for Switching Between Specific Antidepressants
  • Efficacy and Tolerability of Tricyclic Antidepressants and Ssris


© 2024 Docslib.org    Feedback